Real‑world patterns of Alzheimer’s disease biomarker testing: Insights from a large‑scale clinical dataset
Sponsored by: Labcorp
Using data from 234,450 patients, this analysis reveals how Alzheimer’s biomarkers are ordered, sequenced, and repeated in real‑world care, highlighting variability beyond clinical trials and the value of large‑scale RWD. Learn how these insights can inform research and diagnostics.
Biopharma teams often make critical decisions without timely expert input. Simulated Advisory Boards deliver expert-informed insights in days, helping teams test assumptions, explore stakeholder perspectives, and identify risks early. Make smarter decisions, faster. Download the white paper.
Our precision oncology solutions empower biomarker-driven clinical trials and CDx development even when tissue is unavailable—for clear insights at every step of development. Meet us May 30 – June 1.
Chemistry Under the Hood Building a chemical characterization strategy for smart cardiac implants that holds up to FDA scrutiny
Sponsored by: Jordi Labs and RQM+
Smart cardiac implants face heightened FDA scrutiny due to their chemical complexity. This white paper explains how early, advanced testing can reduce delays, costs, and regulatory risk while supporting smoother PMA review. Download the white paper to learn more.
Download this ebook to explore how biomarkers enable precision medicine across drug discovery and clinical development. Learn key strategies, real-world case studies, and emerging technologies that improve trial success and patient stratification.
